What is Mid-Florida Pathology?
Mid-Florida Pathology operates as a critical diagnostic partner for independent medical practitioners, offering a comprehensive suite of services that span Dermatology, Gastrointestinal Pathology, and Cytopathology. By bridging the gap between the technical sophistication of a national laboratory and the personalized, agile service model required by local clinics, the company has carved out a distinct market position. Their operational framework is built on a foundation of 24-hour turnaround times, robust IT integration, and extensive insurance network coverage, which collectively streamline the laboratory experience for both providers and patients. This infrastructure is designed to alleviate the administrative and technical burdens on independent practices, allowing for improved clinical outcomes and operational efficiency.
How much funding has Mid-Florida Pathology raised?
Mid-Florida Pathology has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Mid-Florida Pathology
PPP
Public-Private Partnership
What's next for Mid-Florida Pathology?
With this late-stage capital infusion, Mid-Florida Pathology is well-positioned to accelerate its market penetration and enhance its technological capabilities. The strategic focus will likely shift toward expanding its diagnostic service portfolio and optimizing its billing and IT support systems to accommodate a broader client base. As the healthcare landscape continues to favor integrated, high-efficiency diagnostic solutions, the company is poised to leverage this financing to strengthen its competitive advantage. Future growth initiatives will likely prioritize the scaling of its laboratory capacity and the deepening of its relationships with independent physician networks, ensuring that the firm remains a cornerstone of the regional healthcare ecosystem.
See full Mid-Florida Pathology company page
